Status:
RECRUITING
Pregnancy and Postpartum CGM in GDM
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Gestational Diabetes
Eligibility:
FEMALE
18+ years
Brief Summary
Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blo...
Detailed Description
Those with GDM in current pregnancy using a Dexcom Continuous Glucose Monitoring (CGM) are eligible for enrollment. Participants use their CGM as usual during pregnancy and wear one sensor postpartum....
Eligibility Criteria
Inclusion
- Diagnosis of gestational diabetes during current pregnancy
- age 18 or older
- prescribed Dexcom G7
Exclusion
- Pregestational diabetes
- known skin adhesive allergy which inhibits ongoing use of CGM
- chronic oral steroid use.
Key Trial Info
Start Date :
August 5 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 15 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07174245
Start Date
August 5 2025
End Date
August 15 2026
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029